However, there was no substantial differences between the two groups regarding clinical stage, gender, metastasis site, treatment modality, pathological type, family history, age, treatment response, disease progression, smoking status, HP, DM, COPD, pulmonary tuberculosis (PTB), BMI, SBP, DBP, hemoglobin, BUN, albumin, ALT, HDL-C, AST, TBil, UA, TC, TG, Cr, LDL-C, FBG, SP, SS, and SC (p > 0.05). This evidence concerns the gene ALB and chronic obstructive pulmonary disease.